Sanofi (SNY) Deferred Taxes (2013 - 2021)

Sanofi (SNY) has 4 years of Deferred Taxes data on file, last reported at -$19.6 million in Q4 2021.

• Quarterly Deferred Taxes rose 1.75% year-over-year to -$19.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $728.8 million (changed N/A YoY) and the FY2025 annual result came in at -$2.8 billion, down 231.28% from the prior year.
• Deferred Taxes advanced to -$19.6 million in Q4 2021 per SNY's latest filing, from -$19.9 million in the prior quarter.
• The five-year high for Deferred Taxes was -$19.6 million in Q4 2021, with the low at -$23.0 million in Q4 2019.
• Average Deferred Taxes over 3 years is -$20.8 million, with a median of -$19.9 million recorded in 2020.
• Year-over-year, Deferred Taxes grew 13.52% in 2020 and increased 1.75% in 2021.
• Sanofi's Deferred Taxes stood at -$23.0 million in 2019, then grew by 13.52% to -$19.9 million in 2020, then gained by 1.75% to -$19.6 million in 2021.
• Business Quant data shows SNY's Deferred Taxes at -$19.6 million in Q4 2021, -$19.9 million in Q4 2020, and -$23.0 million in Q4 2019.